BR0308785A - Derivados de alcoxipiridina - Google Patents
Derivados de alcoxipiridinaInfo
- Publication number
- BR0308785A BR0308785A BR0308785-9A BR0308785A BR0308785A BR 0308785 A BR0308785 A BR 0308785A BR 0308785 A BR0308785 A BR 0308785A BR 0308785 A BR0308785 A BR 0308785A
- Authority
- BR
- Brazil
- Prior art keywords
- substituted
- derivatives
- alkoxypyridine
- imidazo
- pyridin
- Prior art date
Links
- -1 3H-imidazo [4,5-b] pyridin-2-yl Chemical group 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 101100396994 Drosophila melanogaster Inos gene Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
"DERIVADOS DE ALCOXIPIRIDINA". A presente invenção refere-se a compostos da fórmula (I) nos quais R1 é 1-4C-alcóxi, A é 1-4C-alquileno, B representa 3H-imidazo[4,5-b]piridin-2-ila, 3H-imidazo[4,5-b]piridin-ila substituída por R2 e/ou R8, 9H-purin-8-ila ou 9H-purin-8-ila substituída por R4 e/ou R5 são inibidores eficazes de iNOs.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02007049 | 2002-03-27 | ||
PCT/EP2003/003076 WO2003080607A1 (en) | 2002-03-27 | 2003-03-25 | Novel alkoxypyridine-derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0308785A true BR0308785A (pt) | 2005-01-11 |
Family
ID=28051741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0308785-9A BR0308785A (pt) | 2002-03-27 | 2003-03-25 | Derivados de alcoxipiridina |
Country Status (19)
Country | Link |
---|---|
US (1) | US7138399B2 (pt) |
EP (1) | EP1490366B1 (pt) |
JP (1) | JP4448695B2 (pt) |
KR (1) | KR20050002910A (pt) |
CN (1) | CN1307176C (pt) |
AT (1) | ATE384722T1 (pt) |
AU (1) | AU2003226706A1 (pt) |
BR (1) | BR0308785A (pt) |
CA (1) | CA2480385A1 (pt) |
DE (1) | DE60318826T2 (pt) |
ES (1) | ES2300599T3 (pt) |
HK (1) | HK1078850A1 (pt) |
IL (1) | IL163625A0 (pt) |
MX (1) | MXPA04009283A (pt) |
NO (1) | NO20044633L (pt) |
NZ (1) | NZ535959A (pt) |
PL (1) | PL372409A1 (pt) |
WO (1) | WO2003080607A1 (pt) |
ZA (1) | ZA200407766B (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2540239A1 (en) * | 2003-10-01 | 2005-04-07 | Altana Pharma Ag | Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
NZ546437A (en) * | 2003-10-01 | 2009-09-25 | Altana Pharma Ag | Imidazopyridine-derivatives as inducible NO-synthase inhibitors |
MXPA06003351A (es) | 2003-10-01 | 2006-06-08 | Altana Pharma Ag | Derivados de imidazopiridina como inhibidores de no-sintasa inducible. |
KR20060092219A (ko) * | 2003-10-01 | 2006-08-22 | 알타나 파마 아게 | 유도성 no-합성효소 억제제로서의 아미노피리딘-유도체 |
JP2007507465A (ja) * | 2003-10-01 | 2007-03-29 | アルタナ ファルマ アクチエンゲゼルシャフト | 誘導性noシンターゼ阻害剤としてのイミダゾピリジン誘導体 |
US8088935B2 (en) | 2003-12-23 | 2012-01-03 | Ironwood Pharmaceuticals, Inc. | Compounds and methods for the treatment of asthma |
KR20070037578A (ko) | 2004-05-28 | 2007-04-05 | 알타나 파마 아게 | 테트라히드로피리도티오펜 |
US7714134B2 (en) | 2004-06-11 | 2010-05-11 | 4Sc Ag | Compounds and use of tetrahydropyridothiophenes |
US7714135B2 (en) | 2005-02-09 | 2010-05-11 | 4Sc Ag | Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer |
EP1851230A1 (en) | 2005-02-11 | 2007-11-07 | Nycomed GmbH | Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer |
ES2328626T3 (es) * | 2005-03-31 | 2009-11-16 | Nycomed Gmbh | Derivados de imidazopiridina utiles como inhibidores de inos. |
AU2006251169A1 (en) | 2005-05-25 | 2006-11-30 | 4Sc Ag | Tetrahydropyridothiophenes for use in the treatment of cancer |
WO2006125813A2 (en) | 2005-05-25 | 2006-11-30 | Nycomed Gmbh | Tetrahydropyridothiophenes for use in the treatment of cancer |
AR055669A1 (es) * | 2005-10-03 | 2007-08-29 | Astrazeneca Ab | Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales. |
AR057525A1 (es) * | 2005-10-03 | 2007-12-05 | Astrazeneca Ab | Compuestos inhibidores selectivos de gsk3 y un proceso para su preparacion |
WO2008031788A1 (en) * | 2006-09-12 | 2008-03-20 | Nycomed Gmbh | Aminoazepine derivatives as highly efficient inhibitors of the inducible nitric oxide synthase |
US20080139608A1 (en) * | 2006-12-06 | 2008-06-12 | Universiteit Leiden | 2,6,8, Trisubstituted 1-deazapurines and their different uses |
MX348131B (es) * | 2011-02-25 | 2017-05-26 | Merck Sharp & Dohme | Novedosos derivados de azabencimidazol ciclico utiles como agentes antidiabeticos. |
US9567330B2 (en) * | 2011-07-15 | 2017-02-14 | Shionogi & Co., Ltd. | Azabenzimidazole derivative having AMPK-activating activity |
GB201512635D0 (en) | 2015-07-17 | 2015-08-26 | Ucl Business Plc | Uses of therapeutic compounds |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE418966B (sv) * | 1974-02-18 | 1981-07-06 | Haessle Ab | Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan |
GB8307865D0 (en) * | 1983-03-22 | 1983-04-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives |
GB8515934D0 (en) * | 1985-06-24 | 1985-07-24 | Janssen Pharmaceutica Nv | (4-piperidinomethyl and-hetero)purines |
SE512835C2 (sv) * | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
-
2003
- 2003-03-25 EP EP03744851A patent/EP1490366B1/en not_active Expired - Lifetime
- 2003-03-25 BR BR0308785-9A patent/BR0308785A/pt not_active IP Right Cessation
- 2003-03-25 DE DE60318826T patent/DE60318826T2/de not_active Expired - Lifetime
- 2003-03-25 JP JP2003578361A patent/JP4448695B2/ja not_active Expired - Fee Related
- 2003-03-25 WO PCT/EP2003/003076 patent/WO2003080607A1/en active IP Right Grant
- 2003-03-25 KR KR10-2004-7015438A patent/KR20050002910A/ko not_active Application Discontinuation
- 2003-03-25 IL IL16362503A patent/IL163625A0/xx unknown
- 2003-03-25 AT AT03744851T patent/ATE384722T1/de not_active IP Right Cessation
- 2003-03-25 PL PL03372409A patent/PL372409A1/xx not_active Application Discontinuation
- 2003-03-25 ES ES03744851T patent/ES2300599T3/es not_active Expired - Lifetime
- 2003-03-25 US US10/509,396 patent/US7138399B2/en not_active Expired - Fee Related
- 2003-03-25 AU AU2003226706A patent/AU2003226706A1/en not_active Abandoned
- 2003-03-25 CN CNB038069172A patent/CN1307176C/zh not_active Expired - Fee Related
- 2003-03-25 NZ NZ535959A patent/NZ535959A/en not_active IP Right Cessation
- 2003-03-25 CA CA002480385A patent/CA2480385A1/en not_active Abandoned
- 2003-03-25 MX MXPA04009283A patent/MXPA04009283A/es active IP Right Grant
-
2004
- 2004-09-27 ZA ZA200407766A patent/ZA200407766B/en unknown
- 2004-10-27 NO NO20044633A patent/NO20044633L/no not_active Application Discontinuation
-
2005
- 2005-11-23 HK HK05110611A patent/HK1078850A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1307176C (zh) | 2007-03-28 |
ES2300599T3 (es) | 2008-06-16 |
JP4448695B2 (ja) | 2010-04-14 |
EP1490366A1 (en) | 2004-12-29 |
AU2003226706A1 (en) | 2003-10-08 |
US20050171125A1 (en) | 2005-08-04 |
DE60318826T2 (de) | 2009-01-22 |
EP1490366B1 (en) | 2008-01-23 |
MXPA04009283A (es) | 2005-01-25 |
CA2480385A1 (en) | 2003-10-02 |
KR20050002910A (ko) | 2005-01-10 |
DE60318826D1 (de) | 2008-03-13 |
ATE384722T1 (de) | 2008-02-15 |
NO20044633L (no) | 2004-12-23 |
IL163625A0 (en) | 2005-12-18 |
CN1642955A (zh) | 2005-07-20 |
JP2005525388A (ja) | 2005-08-25 |
NZ535959A (en) | 2006-05-26 |
WO2003080607A1 (en) | 2003-10-02 |
ZA200407766B (en) | 2006-06-28 |
HK1078850A1 (en) | 2006-03-24 |
PL372409A1 (en) | 2005-07-25 |
US7138399B2 (en) | 2006-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0308785A (pt) | Derivados de alcoxipiridina | |
ATE301653T1 (de) | Pyrazolopyridine | |
MXPA04001323A (es) | Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso. | |
MA27933A1 (fr) | Inhibiteurs de l'activite de akt | |
NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
AP1902A (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials | |
DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
IL158667A0 (en) | Imidazo [1,2-a] pyridine derivatives for the prophylaxis and treatment of herpes viral infections | |
MXPA04012965A (es) | Inhibidores virales. | |
NZ595000A (en) | Imidazo[4,5-c]pyridine derivative for treating viral infections | |
NO20063132L (no) | Naftyridinderivater og deres anvendelse som modulatorer av muskarinreceptorer | |
MXPA03012013A (es) | Derivados de 1-oxa-2,8-diaza-spiro[4,5]dec-2-eno sustituidos como medicamento para el tratamiento de dolor. | |
CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
DE60212949D1 (de) | Antivirale pyrazolopyridin verbindungen | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
NO20032841L (no) | Heterocykloindol- eller azaindol-forbindelser som 5- hydroksytryptamin-6-ligander | |
MXPA05009688A (es) | Derivados de naftiridina como agentes antibacterianos. | |
ATE274515T1 (de) | Pyrazolopyridinderivate | |
DE60222465D1 (de) | Pyrazolopyridin-derivate als antiherpesmittel | |
BR0004787A (pt) | Processo para a preparação de compostos pirazolo[4,3-d] pirimidin-7-onas-3-piridilsulfonila bem como intermediários dos mesmos | |
DE60130009D1 (de) | Makrolide | |
TR200101443T2 (tr) | 8-siyano-1-siklopropil-7- (1S,6S-2,8-diazabisiklo[4,3,0]-nonan-8-il) -6-flüoro-1, 4-dihidro-4-okso-3-kinolinkarboksilik asidin yarı-hidroklorürü | |
SE0100297D0 (sv) | New compounds | |
WO2002057286A3 (en) | 9-amino erythromycin derivatives with antibacterial activity | |
HUP0004621A2 (hu) | Egy HIV proteáz inhibitor fokozott orális felszívódást és biológiai hozzáférhetőséget mutató szulfátsója |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A, 8A E 9A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 7A, 8A E 9A ANUIDADES. |